[1]
Dr. Anil Kumar Muthineni 2021. FRACTURE RISK ASSOCIATED WITH ORAL CORTICOSTEROID USE: A RETROSPECTIVE COHORT STUDY ON DOSE-RESPONSE AND THE REVERSIBILITY OF FRACTURE RISK POST-THERAPY. Journal of Population Therapeutics and Clinical Pharmacology. 28, 2 (Dec. 2021), 1206–1213. DOI:https://doi.org/10.53555/22stae90.